A prospective study of preventive effect of tadalafil on urethral stricture after transurethral surgery

A prospective study of preventive effect of tadalafil on urethral stricture after transurethral surgery - Preventive effect of tadalafil on urethral stricture after transurethral surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027612

Enrollment

100

Registered

2017-06-05

Start date

2017-02-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urethral stricture

Interventions

tadarafil 5mg per day orally no medication

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male patients receiving transurethral surgery

Exclusion criteria

Exclusion criteria: NO user, allergy to tadalafil and ischemic heart disease

Design outcomes

Primary

Measure	Time frame
Frequency of urethral stricture	—

Countries

Japan

Contacts

Public ContactHisashi Matsushima

Tokyo Metropolitan Police Hospital Department of Urology

yakuzai@keisatsubyoin.or.jp03-5343-5611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026